Higher versus lower sodium intake for preterm infants.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
12 10 2023
Historique:
pmc-release: 12 10 2024
medline: 1 11 2023
pubmed: 12 10 2023
entrez: 12 10 2023
Statut: epublish

Résumé

Infants born preterm are at increased risk of early hypernatraemia (above-normal blood sodium levels) and late hyponatraemia (below-normal blood sodium levels). There are concerns that imbalances of sodium intake may impact neonatal morbidities, growth and developmental outcomes. To determine the effects of higher versus lower sodium supplementation in preterm infants. We searched CENTRAL in February 2023; and MEDLINE, Embase and trials registries in March and April 2022. We checked reference lists of included studies and systematic reviews where subject matter related to the intervention or population examined in this review. We compared early (< 7 days following birth), late (≥ 7 days following birth), and early and late sodium supplementation, separately. We included randomised, quasi-randomised or cluster-randomised controlled trials that compared nutritional supplementation that included higher versus lower sodium supplementation in parenteral or enteral intake, or both. Eligible participants were preterm infants born before 37 weeks' gestational age or with a birth weight less than 2500 grams, or both. We excluded studies that had prespecified differential water intakes between groups. Two review authors independently assessed eligibility and risk of bias, and extracted data. We used the GRADE approach to assess the certainty of evidence. We included nine studies in total. However, we were unable to extract data from one study (20 infants); some studies contributed to more than one comparison. Eight studies (241 infants) were available for quantitative meta-analysis. Four studies (103 infants) compared early higher versus lower sodium intake, and four studies (138 infants) compared late higher versus lower sodium intake. Two studies (103 infants) compared intermediate sodium supplementation (≥ 3 mmol/kg/day to < 5 mmol/kg/day) versus no supplementation, and two studies (52 infants) compared higher sodium supplementation (≥ 5 mmol/kg/day) versus no supplementation. We assessed only two studies (63 infants) as low risk of bias. Early (less than seven days following birth) higher versus lower sodium intake Early higher versus lower sodium intake may not affect mortality (risk ratio (RR) 1.02, 95% confidence interval (CI) 0.38 to 2.72; I Early (< 7 days following birth) higher sodium supplementation may result in an increased incidence of hypernatraemia and may result in a similar incidence of hyponatraemia compared to lower supplementation. We are uncertain if there are any effects on mortality or neonatal morbidity. Growth and longer-term development outcomes were largely unreported in trials of early sodium supplementation. Late (≥ 7 days following birth) higher sodium supplementation may reduce the incidence of hyponatraemia. We are uncertain if late higher intake affects the incidence of hypernatraemia compared to lower supplementation. Late higher sodium intake may reduce postnatal growth failure. We are uncertain if late higher sodium intake affects mortality, other neonatal morbidities or longer-term development. We are uncertain if early and late higher versus lower sodium supplementation affects outcomes.

Sections du résumé

BACKGROUND
Infants born preterm are at increased risk of early hypernatraemia (above-normal blood sodium levels) and late hyponatraemia (below-normal blood sodium levels). There are concerns that imbalances of sodium intake may impact neonatal morbidities, growth and developmental outcomes.
OBJECTIVES
To determine the effects of higher versus lower sodium supplementation in preterm infants.
SEARCH METHODS
We searched CENTRAL in February 2023; and MEDLINE, Embase and trials registries in March and April 2022. We checked reference lists of included studies and systematic reviews where subject matter related to the intervention or population examined in this review. We compared early (< 7 days following birth), late (≥ 7 days following birth), and early and late sodium supplementation, separately.
SELECTION CRITERIA
We included randomised, quasi-randomised or cluster-randomised controlled trials that compared nutritional supplementation that included higher versus lower sodium supplementation in parenteral or enteral intake, or both. Eligible participants were preterm infants born before 37 weeks' gestational age or with a birth weight less than 2500 grams, or both. We excluded studies that had prespecified differential water intakes between groups.
DATA COLLECTION AND ANALYSIS
Two review authors independently assessed eligibility and risk of bias, and extracted data. We used the GRADE approach to assess the certainty of evidence.
MAIN RESULTS
We included nine studies in total. However, we were unable to extract data from one study (20 infants); some studies contributed to more than one comparison. Eight studies (241 infants) were available for quantitative meta-analysis. Four studies (103 infants) compared early higher versus lower sodium intake, and four studies (138 infants) compared late higher versus lower sodium intake. Two studies (103 infants) compared intermediate sodium supplementation (≥ 3 mmol/kg/day to < 5 mmol/kg/day) versus no supplementation, and two studies (52 infants) compared higher sodium supplementation (≥ 5 mmol/kg/day) versus no supplementation. We assessed only two studies (63 infants) as low risk of bias. Early (less than seven days following birth) higher versus lower sodium intake Early higher versus lower sodium intake may not affect mortality (risk ratio (RR) 1.02, 95% confidence interval (CI) 0.38 to 2.72; I
AUTHORS' CONCLUSIONS
Early (< 7 days following birth) higher sodium supplementation may result in an increased incidence of hypernatraemia and may result in a similar incidence of hyponatraemia compared to lower supplementation. We are uncertain if there are any effects on mortality or neonatal morbidity. Growth and longer-term development outcomes were largely unreported in trials of early sodium supplementation. Late (≥ 7 days following birth) higher sodium supplementation may reduce the incidence of hyponatraemia. We are uncertain if late higher intake affects the incidence of hypernatraemia compared to lower supplementation. Late higher sodium intake may reduce postnatal growth failure. We are uncertain if late higher sodium intake affects mortality, other neonatal morbidities or longer-term development. We are uncertain if early and late higher versus lower sodium supplementation affects outcomes.

Identifiants

pubmed: 37824273
doi: 10.1002/14651858.CD012642.pub2
pmc: PMC10569379
doi:

Substances chimiques

Sodium 9NEZ333N27
Sodium, Dietary 0

Types de publication

Meta-Analysis Systematic Review Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

CD012642

Informations de copyright

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Références

Pediatrics. 1962 Dec;30:909-16
pubmed: 13948753
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):e123-e129
pubmed: 27276434
Helv Paediatr Acta. 1984 Dec;39(5-6):405-18
pubmed: 6543853
J Pediatr Gastroenterol Nutr. 2005 Nov;41 Suppl 2:S1-87
pubmed: 16254497
Acta Paediatr Scand. 1971 Jul;60(4):407-16
pubmed: 4104108
Pediatr Res. 1976 May;10(5):526-31
pubmed: 934723
Pediatr Emerg Care. 2013 Jul;29(7):808-13
pubmed: 23823259
Br Med J. 1976 Dec 4;2(6048):1347-50
pubmed: 1000228
Pediatr Res. 1976 May;10(5):522-6
pubmed: 934722
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6338-6345
pubmed: 33879015
Acta Paediatr. 1992 Mar;81(3):207-12
pubmed: 1511192
Arch Dis Child. 1988 Jun;63(6):656-7
pubmed: 3389898
Biol Neonate. 2001 Feb;79(2):109-12
pubmed: 11223652
Pediatrics. 1988 Oct;82(4):527-32
pubmed: 3174313
J Paediatr Child Health. 2015 Jul;51(7):713-21
pubmed: 25644196
Arch Dis Child. 1984 Oct;59(10):945-50
pubmed: 6497431
N Engl J Med. 2011 Jan 20;364(3):255-64
pubmed: 21247316
BMC Pediatr. 2014 Feb 18;14:48
pubmed: 24548745
Arch Dis Child. 1984 May;59(5):423-9
pubmed: 6732272
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
BMJ. 1997 Feb 8;314(7078):404-8
pubmed: 9040385
J Paediatr Child Health. 2006 Dec;42(12):771-4
pubmed: 17096711
J Perinatol. 2003 Sep;23(6):473-6
pubmed: 13679934
Acta Paediatr Scand. 1971 Jul;60(4):417-27
pubmed: 4104109
Zhongguo Dang Dai Er Ke Za Zhi. 2007 Aug;9(4):297-300
pubmed: 17706024
Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F19-23
pubmed: 10634836
Cochrane Database Syst Rev. 2001;(3):CD000503
pubmed: 11686962
Cochrane Database Syst Rev. 2023 Oct 12;10:CD012642
pubmed: 37824273
East Afr Med J. 1992 Oct;69(10):591-5
pubmed: 1473517
J Korean Med Sci. 2015 Mar;30(3):283-9
pubmed: 25729251
J Pediatr. 2003 Aug;143(2):171-9
pubmed: 12970628
Srp Arh Celok Lek. 1998 Jan-Feb;126(1-2):6-12
pubmed: 9525076
J Pediatr. 1993 Aug;123(2):301-6
pubmed: 8345431
JAMA. 1983 Jul 15;250(3):370-3
pubmed: 6343656
J Pediatr. 1992 Jan;120(1):99-106
pubmed: 1731034
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
Acta Paediatr. 2013 Nov;102(11):1067-74
pubmed: 23855971
Arch Dis Child Fetal Neonatal Ed. 2000 Jan;82(1):F24-8
pubmed: 10634837
Arch Ophthalmol. 2005 Jul;123(7):991-9
pubmed: 16009843
J Korean Med Sci. 2015 Apr;30(4):456-62
pubmed: 25829814
J Paediatr Child Health. 1994 Oct;30(5):406-11
pubmed: 7833075
Acta Paediatr Scand Suppl. 1989;360:37-42
pubmed: 2642254
Acta Paediatr Jpn. 1994 Jun;36(3):250-5
pubmed: 8091971
Acta Paediatr. 1998 Nov;87(11):1185-90
pubmed: 9846922
J Pediatr. 1991 Apr;118(4 Pt 1):615-20
pubmed: 2007939
Pediatr Neonatol. 2012 Dec;53(6):329-33
pubmed: 23276435
Am J Dis Child. 1983 Mar;137(3):215-9
pubmed: 6823919
J Pediatr. 1982 Sep;101(3):423-32
pubmed: 7050331
J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):85-91
pubmed: 19881390
Acta Paediatr Scand. 1981 Mar;70(2):183-7
pubmed: 7015783
Mymensingh Med J. 2012 Jan;21(1):103-8
pubmed: 22314463
J Perinatol. 2008 Jan;28(1):29-33
pubmed: 17989698
JPEN J Parenter Enteral Nutr. 2016 Mar;40(3):342-9
pubmed: 25406227
Bol Med Hosp Infant Mex. 1988 Dec;45(12):817-22
pubmed: 3240345
Arch Dis Child. 1992 Oct;67(10 Spec No):1154-61
pubmed: 1444548
Indian Pediatr. 1985 Sep;22(9):708-9
pubmed: 3914468
Pediatrics. 2009 Nov;124(5):e1014-6
pubmed: 19858147
Arch Dis Child Fetal Neonatal Ed. 2002 Mar;86(2):F120-3
pubmed: 11882555
J Am Diet Assoc. 1996 Sep;96(9):880-4
pubmed: 8784332
Arch Dis Child Fetal Neonatal Ed. 2001 Jul;85(1):F29-32
pubmed: 11420318
Arch Dis Child. 1983 May;58(5):343-5
pubmed: 6859913
Arch Dis Child. 1983 May;58(5):335-42
pubmed: 6859912
Pediatr Res. 1977 Nov;11(11):1162-4
pubmed: 917616
Pediatrics. 1995 Sep;96(3 Pt 1):484-9
pubmed: 7651782
Int J Pediatr Nephrol. 1983 Jun;4(2):75-8
pubmed: 6618771
J Pediatr. 1989 Aug;115(2):285-90
pubmed: 2526866
Acta Paediatr. 2012 Mar;101(3):236-41
pubmed: 22040311
Clin Nutr. 2018 Dec;37(6 Pt B):2344-2353
pubmed: 30064846
Indian Pediatr. 2023 Feb 15;60(1):146-148
pubmed: 36786184
East Afr Med J. 1992 Nov;69(11):627-30
pubmed: 1298620
Acta Paediatr Scand. 1987 Jan;76(1):47-53
pubmed: 3565001
Acta Paediatr. 1995 Nov;84(11):1312-4
pubmed: 8580634
J Pediatr. 1982 Nov;101(5):761-3
pubmed: 6957582
Pediatrics. 2009 Oct;124(4):e655-61
pubmed: 19752079
Arch Dis Child. 1992 Oct;67(10 Spec No):1140-5
pubmed: 1444546
J Perinatol. 2011 Mar;31(3):193-8
pubmed: 20671713
Acta Paediatr. 2014 May;103(5):498-503
pubmed: 24460697
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Natasha Diller (N)

Newborn Care, Royal Prince Alfred Hospital, Sydney, Australia.

David A Osborn (DA)

Central Clinical School, School of Medicine, The University of Sydney, Sydney, Australia.

Pita Birch (P)

Department of Neonatology, Mater Mother's Hospitals South Brisbane, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH